Patents by Inventor Daniel EMERLING

Daniel EMERLING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRES
    Publication number: 20220155319
    Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.
    Type: Application
    Filed: January 31, 2022
    Publication date: May 19, 2022
    Inventors: Jeff DeFALCO, Daniel EMERLING, Shaun LIPPOW, Sean CARROLL, Wayne VOLKMUTH, Norm GREENBERG, Tito SERAFINI
  • USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRES
    Publication number: 20200355698
    Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.
    Type: Application
    Filed: April 9, 2020
    Publication date: November 12, 2020
    Inventors: Jeff DeFalco, Daniel Emerling, Shaun Lippow, Sean Carroll, Wayne Volkmuth, Norm Greenberg, Tito Serafini
  • Use of nanoexpression to interrogate antibody repertoires
    Patent number: 10620219
    Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: April 14, 2020
    Assignee: ATRECA, INC.
    Inventors: Jeff DeFalco, Daniel Emerling, Shaun Lippow, Sean Carroll, Wayne Volkmuth, Norm Greenberg, Tito Serafini
  • USE OF NANOEXPRESSION TO INTERROGATE ANTIBODY REPERTOIRES
    Publication number: 20180100864
    Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.
    Type: Application
    Filed: December 13, 2017
    Publication date: April 12, 2018
    Inventors: Jeff DeFALCO, Daniel EMERLING, Shaun LIPPOW, Sean CARROLL, Wayne VOLKMUTH, Norm GREENBERG, Tito SERAFINI